Latest News of NEWR
Investing in Newron Pharmaceuticals (VTX:NWRN) three years ago would have delivered you a 294% gain
By Yahoo! Finance |
4 weeks ago
Newron Pharmaceuticals' stock price has surged 294% in three years, with revenue growing at 16% annually. While the company isn't profitable yet, the market shows optimism. Shareholders received a 28%...
We Might See A Profit From Newron Pharmaceuticals S.p.A. (VTX:NWRN) Soon
By Yahoo! Finance |
2 months ago
Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focusing on CNS and pain treatments. Analysts predict the company will break even in 2024, with a projected 51% annual growth rate. Despite...